Helen Boyle

1.1k total citations
38 papers, 645 citations indexed

About

Helen Boyle is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Helen Boyle has authored 38 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Helen Boyle's work include Renal cell carcinoma treatment (8 papers), Testicular diseases and treatments (7 papers) and Renal and related cancers (7 papers). Helen Boyle is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Testicular diseases and treatments (7 papers) and Renal and related cancers (7 papers). Helen Boyle collaborates with scholars based in France, Switzerland and United Kingdom. Helen Boyle's co-authors include Nicolas Mottet, Aude Fléchon, Pierre Méeus, Jean‐Pierre Droz, Jérôme Fayette, Dominique Ranchère, Laurent Alberti, Jean‐Yves Blay, Isabelle Ray Coquard and Stéphane Oudard and has published in prestigious journals such as The Lancet Oncology, European Journal of Cancer and Urology.

In The Last Decade

Helen Boyle

36 papers receiving 629 citations

Peers

Helen Boyle
Tal Sella Israel
Louise Stanton United Kingdom
Aart Beeker Netherlands
Vikram M. Narayan United States
Ivy Altomare United States
Helen Boyle
Citations per year, relative to Helen Boyle Helen Boyle (= 1×) peers Mahdi Aghili

Countries citing papers authored by Helen Boyle

Since Specialization
Citations

This map shows the geographic impact of Helen Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Boyle more than expected).

Fields of papers citing papers by Helen Boyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Boyle. The network helps show where Helen Boyle may publish in the future.

Co-authorship network of co-authors of Helen Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Boyle. A scholar is included among the top collaborators of Helen Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Boyle. Helen Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chabaud, Sylvie, Aude Fléchon, Helen Boyle, et al.. (2025). Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin. European Journal of Cancer. 222. 115427–115427. 1 indexed citations
2.
Peyrat, Patrice, et al.. (2024). Bone Metastases in Non-Seminomatous Germ Cell Tumors: A 20-Year Retrospective Analysis. Journal of Clinical Medicine. 13(11). 3280–3280. 1 indexed citations
3.
Lefèvre, Marie, Brigitte Dananché, Hans Kromhout, et al.. (2024). Parental occupations at birth and risk of adult testicular germ cell tumors in offspring: a French nationwide case–control study. Frontiers in Public Health. 11. 1303998–1303998. 3 indexed citations
4.
Giraudet, Anne‐Laure, Armelle Vinceneux, Jean‐Noël Badel, et al.. (2023). Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma. Pharmaceuticals. 16(7). 995–995. 6 indexed citations
5.
Marec‐Bérard, Perrine, Lidia Delrieu, Olivia Pérol, et al.. (2021). Implementation of a Prevention Program Based on Adapted Physical Activity and Recommendations for Adolescents and Young Adults with Cancer: PREVAPAJA Study. Journal of Adolescent and Young Adult Oncology. 11(2). 189–201. 1 indexed citations
6.
Mottet, Nicolas, María J. Ribal, Helen Boyle, et al.. (2020). Management of bladder cancer in older patients: Position paper of a SIOG Task Force. Journal of Geriatric Oncology. 11(7). 1043–1053. 49 indexed citations
7.
Boyle, Helen, et al.. (2019). The Value of Art Therapy: An Intervention to Enhance Emotional Health of Children with Hearing Loss. NSUWorks (Nova Southeastern University). 39(1). 6. 2 indexed citations
8.
Boyle, Helen, et al.. (2019). Qualitative, Exploratory, and Multidimensional Study of Telepresence Robots for Overcoming Social Isolation of Children and Adolescents Hospitalized in Onco-Hematology. Journal of Adolescent and Young Adult Oncology. 9(1). 90–95. 7 indexed citations
10.
Carretier, Julien, Helen Boyle, Thierry Philip, et al.. (2015). A Review of Health Behaviors in Childhood and Adolescent Cancer Survivors: Toward Prevention of Second Primary Cancer. Journal of Adolescent and Young Adult Oncology. 5(2). 78–90. 46 indexed citations
11.
Pouessel, Damien, Sylvie Chevret, Frédéric Rolland, et al.. (2015). Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?. European Journal of Cancer. 54. 69–74. 11 indexed citations
12.
Bertrand, A., et al.. (2015). Gestion des aplasies fébriles chez les adolescents et jeunes adultes : différences de pratiques entre secteurs adultes et pédiatriques. Bulletin du Cancer. 102(11). 915–922. 1 indexed citations
13.
Carretier, Julien, Helen Boyle, Thierry Philip, et al.. (2015). Facteurs comportementaux et professionnels et prévention des seconds cancers primitifs après un cancer dans l’enfance ou dans l’adolescence : état des connaissances. Bulletin du Cancer. 102(7-8). 665–673. 1 indexed citations
14.
Droz, Jean-Pierre, Matti Aapro, Lodovico Balducci, et al.. (2014). Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. The Lancet Oncology. 15(9). e404–e414. 166 indexed citations
15.
Béranger, Rémi, Élodie Faure, Aude Fléchon, et al.. (2014). Tumeurs germinales du testiculeet expositions précoces aux pesticides: étude pilote TESTEPERA. Bulletin du Cancer. 101(3). 225–235. 11 indexed citations
16.
Boyle, Helen. (2012). Rape and the Media: Victim’s Rights to Anonymity and Effects of Technology on the Standard of Rape Coverage.. 3(3). 1 indexed citations
17.
Boyle, Helen, G. Chatté, Eric Roche, et al.. (2011). Sarcoid-Like Granulomatosis and Testicular Germ Cell Tumor: The ‘Great Imitator’. Oncology. 81(5-6). 319–324. 16 indexed citations
18.
You, Benoît, Helen Boyle, Jean‐Pierre Droz, et al.. (2010). Predictive Value of Modeled AUCAFP-hCG, a Dynamic Kinetic Parameter Characterizing Serum Tumor Marker Decline in Patients With Nonseminomatous Germ Cell Tumor. Urology. 76(2). 423–429.e2. 10 indexed citations
19.
Camparo, Philippe, Helen Boyle, François Germain, et al.. (2009). Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(4). 375–381. 23 indexed citations
20.
Fayette, Jérôme, Isabelle Ray Coquard, Laurent Alberti, et al.. (2006). ET-743: a novel agent with activity in soft-tissue sarcomas. Current Opinion in Oncology. 18(4). 347–353. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026